image: iStock

FDA clears AI technology that evaluates echocardiograms

A medical technology company specializing in applying artificial intelligence to cardiovascular imaging has received clearance from the Food and Drug Administration for its fully automated video clip selection and calculation of left ventricular ejection fraction.

The software from San Francisco-based Bay Labs—which can be integrated into any DICOM PACS medical imaging environment—is expected to improve cardiovascular disease management and patient outcomes through earlier detection and monitoring, according to Charles Cadieu, co-founder and CEO of the company.

Read More on Health Data Management